Zealand Pharma — Director's Dealing 2016

Mar 17, 2016

Copenhagen, 17 March 2016 – Pursuant to the Danish Securities Trading Act,
section 28a, Zealand discloses information on transactions with the company’s
shares and related securities by executives and persons/companies closely
related to them.

With reference to the above, Zealand announces that it has received information
on the below transactions for disclosure.

Name: Martin Nicklasson
Reason: Chairman, Board of Directors
Issuer: Zealand Pharma A/S
Designation: Shares
ISIN Code: DK0060257814
Transaction: Purchase of shares
Trading Date: 16 March 2016
Market: Nasdaq Copenhagen
Number: 1,000
Price: DKK 116.50
Total value: DKK 116,500.00